drugset
drugset / Trial / NCT03210740

Safety and Efficacy Study of AM001 Cream in the Treatment of Actinic Keratosis

NCT03210740 ↗

Phase 2 Completed 30 enrolled AmDerma
RandomizedParallel-groupTriple-blindTreatment

Summary

To compare the safety and efficacy profiles of AM001 Cream, 7.5% and its vehicle cream in the treatment of Actinic Keratosis (AK) Lesions

Timeline

Start
2017-06-06
Primary completion
2018-02-13
Completion
2018-04-24

Drugs

EvaluationDrugModalityDoseRoute
Subject AM001 Unknown 7.5 % —

Indications

actinic keratosis